Tyra Biosciences annual total assets
2020
2021
2022
2023
2024
2025
Tyra Biosciences Total Assets Growth & History (TYRA)
Tyra Biosciences's total assets was $282.6M for fiscal 2025.
View full Tyra Biosciences company overviewTyra Biosciences annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $282.6M | −$80.9M | −22.27% |
| 2024 | 2024-12-31 | $363.6M | $137.7M | +60.97% |
| 2023 | 2023-12-31 | $225.9M | −$40.3M | −15.15% |
| 2022 | 2022-12-31 | $266.2M | −$40.5M | −13.21% |
| 2021 | 2021-12-31 | $306.7M | $290.7M | +1815.56% |
| 2020 | 2020-12-31 | $16.0M | — | — |
Tyra Biosciences quarterly total assets
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $383.4M | $61.9M | +19.24% |
| Q1 2026 | 2026-03-31 | $412.0M | $68.6M | +19.96% |
| Q4 2025 | 2025-12-31 | $282.6M | −$80.9M | −22.27% |
| Q3 2025 | 2025-09-30 | $301.9M | −$78.7M | −20.69% |
| Q2 2025 | 2025-06-30 | $321.5M | −$71.0M | −18.08% |
| Q1 2025 | 2025-03-31 | $343.5M | −$61.3M | −15.14% |
| Q4 2024 | 2024-12-31 | $363.6M | $137.7M | +60.97% |
| Q3 2024 | 2024-09-30 | $380.6M | $142.2M | +59.67% |
| Q2 2024 | 2024-06-30 | $392.5M | $142.4M | +56.98% |
| Q1 2024 | 2024-03-31 | $404.7M | $149.7M | +58.69% |
| Q4 2023 | 2023-12-31 | $225.9M | −$40.3M | −15.15% |
| Q3 2023 | 2023-09-30 | $238.4M | −$37.6M | −13.63% |
| Q2 2023 | 2023-06-30 | $250.0M | −$37.1M | −12.92% |
| Q1 2023 | 2023-03-31 | $255.1M | −$43.9M | −14.69% |
| Q4 2022 | 2022-12-31 | $266.2M | −$40.5M | −13.21% |
| Q3 2022 | 2022-09-30 | $276.0M | −$40.0M | −12.65% |
| Q2 2022 | 2022-06-30 | $287.1M | — | — |
| Q1 2022 | 2022-03-31 | $299.0M | — | — |
| Q4 2021 | 2021-12-31 | $306.7M | $290.7M | +1815.56% |
| Q3 2021 | 2021-09-30 | $316.0M | — | — |
| Q4 2020 | 2020-12-31 | $16.0M | — | — |
Tyra Biosciences total assets trends
Over the last five fiscal years, Tyra Biosciences's total assets increased from $16.0M to $282.6M, a change of $266.6M. The latest reported quarter, Q2 2026, shows $383.4M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tyra Biosciences source filings ↗